| Old Articles: <Older 5031-5040 Newer> |
|---|
 |
Pharmaceutical Executive
August 1, 2008
J. Brooker Aker |
Search for: Meaning Here's how to search for meaning through unstructured data.   |
Pharmaceutical Executive
August 1, 2008
Patrick Clinton |
Cutter's Way It's time to get drug cases out of the courts entirely. |
The Motley Fool
August 18, 2008
Brian Lawler |
When Breaking Up Isn't Hard to Do PDL BioPharma and Enzon are the latest biotechs looking to spin off parts of their business. |
The Motley Fool
August 18, 2008
Brian Orelli |
Foolish Forecast: Taking Medtronic to Heart In advance of earnings analysts expect Medtronic, with another medical device approval, to boost revenues 17%. |
Scientific American
August 2008
Christine Soares |
Nicotine Replacement Drug's Bad Trip Pfizer's smoking-cessation aid tied to psychiatric episodes. |
Insurance & Technology
July 29, 2008
Anthony O'Donnell |
Regence Drives Successful EMR Pilot Demonstrating the potential for payer-driven electronic medical record solutions, Regence has conducted a one-year pilot project to test the feasibility of connecting an entire medical community |
The Motley Fool
August 15, 2008
Brian Orelli |
Syneron Medical's Bipolar Growth While U.S. sales sink, international sales are keeping the medical laser making company afloat. |
The Motley Fool
August 14, 2008
Brian Lawler |
A Potentially Painless PDUFA Date King Pharmaceuticals and Pain Therapeutics get an appointment with the FDA. |
The Motley Fool
August 14, 2008
Brian Lawler |
Genentech Asks Roche to Pay Up In one of the more friendly spurnings of a buyout offer in recent months, Genentech calls Roche's $89-per-share buyout offer too low, and very nicely implies that Roche should up its bid. |
The Motley Fool
August 14, 2008
Brian Orelli |
Wald Equation Won't Derail Boston Scientific The Wall Street Journal reanalyzes Boston Scientific's data on its new drug-eluding stent, but will the FDA care? |
| <Older 5031-5040 Newer> Return to current articles. |
